GeneScience Pharmaceuticals Co

Company snapshot

GeneScience Pharmaceuticals Co., Ltd. (GenSci), was established in 1996. GenSci's production facility is located in one of the top 6 national biomedical centers, Changchun High-Tech Development Zone, GenSci's manufacturing facility covers more than 20,000 sq.m. of land with 11,000 sq.m. of production area. It is one of the largest and best-equipped biopharmaceutical productions in China. As one of

• 3 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for GeneScience Pharmaceuticals Co. Not investment advice.

• What is GeneScience Pharmaceuticals Co?

  Changchun GeneScience Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Gastric or Gastroesophageal Junction Cancer, Dwarfism, Growth Hormone Deficiency. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and

• Is GeneScience Pharmaceuticals Co publicly traded?

  GeneScience Pharmaceuticals Co appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does GeneScience Pharmaceuticals Co develop or market?

  We link 4 drug profile(s) where GeneScience Pharmaceuticals Co is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/changchun-genescience-pharmaceutical-co#company-drugs.

• What are the latest developments for GeneScience Pharmaceuticals Co?

  In the last 12 months our linked public records show 3 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does GeneScience Pharmaceuticals Co focus on?

  GeneScience Pharmaceuticals Co focuses on Advanced Gastric or Gastroesophageal Junction Cancer, Dwarfism, Growth Hormone Deficiency based on our analysis of their pipeline programs and drug development activities.